ReNerve Limited (ASX:RNV)

Australia · Delayed Price · Currency is AUD

0.0800

+0.0010 (1.27%)

At close: Jul 9, 2026

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Medical Devices For Damaged Peripheral Nerves	271.71K	177.37K	128.49K
Medical Devices For Damaged Peripheral Nerves Growth	53.18%	38.04%	-
Total	271.71K	177.37K	128.49K
Total Growth	53.18%	38.04%	-

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
New Zealand	738.00	789.00	-
New Zealand Growth	-6.46%	-	-
United States	267.87K	176.58K	-
United States Growth	51.70%	-	-
Hong Kong	3.10K	-	-
Australia	-	-	128.49K
Total	271.71K	177.37K	128.49K
Total Growth	53.18%	38.04%	-